Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

King Raises Medicaid Rebate Underpayments To $65 Mil.

This article was originally published in The Pink Sheet Daily

Executive Summary

The increased amount includes $18.9 mil. in estimated underpayments following completion of an internal audit. Final amount due to the government could be higher once SEC completes its investigation of King’s accounting practices.

You may also be interested in...



King To Set Aside Additional $65 Mil. To Settle SEC/OIG Investigation

The company’s Medicaid underpayment liability is approximately $130 mil. King says its wholesaler inventory levels have begun to normalize with 2.4 months of Rx demand across its four key products.

Pazdur’s Big Moment: ‘Project Odyssey’ Webinar Gives Oncology Chief External Buy-In On His Ideas To Revamp ODAC

OCE Director Richard Pazdur is known for cultivating 'Pazdur moments' during advisory committees when he feels the conversation has gone off track. A recent webinar with ODAC members created a perfect opportunity to promote his agenda.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058646

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel